Carrie Cox
Chairman en ORGANON & CO. .
Fortuna: 11 M $ al 31/03/2024
Perfil
Carrie S. Cox es presidenta de Organon & Co, presidenta de Advantagene, Inc, presidenta de Selecta Biosciences, Inc, directora independiente de Cardinal Health, Inc, directora independiente de Texas Instruments Incorporated y miembro del consejo de administración del Museo de Arqueología y Antropología de la Universidad de Pensilvania. Forma parte del Consejo de Administración de Cardinal Health, Inc. y de Texas Instruments Incorporated. Anteriormente, la Sra. Cox fue presidenta de Array BioPharma, Inc., presidenta de electroCore, Inc., directora independiente de Celgene Corp., presidenta de Global Pharmaceuticals y vicepresidenta ejecutiva de Schering-Plough Corp., vicepresidenta senior de Global Business Management de Pharmacia & Upjohn, Inc, presidenta de Global Prescription Business y vicepresidenta ejecutiva de Pharmacia Corp., miembro de la Harvard T.H. Chan School of Public Health, directora de Novartis Corp., presidenta de Prism Pharmaceuticals, Inc. y vicepresidenta de Women's Healthcare de Wyeth-Ayerst Research. También formó parte del consejo de administración de Humacyte, Inc. y Renetx Bio, Inc. Se licenció en el Massachusetts College of Pharmacy & Health Science.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
28/02/2024 | 35 801 ( 0.00% ) | 6 M $ | 31/03/2024 | |
CARDINAL HEALTH, INC.
0.02% | 18/09/2023 | 41 631 ( 0.02% ) | 5 M $ | 31/03/2024 |
0.13% | 15/01/2024 | 212 881 ( 0.13% ) | 138 373 $ | 31/03/2024 |
ORGANON & CO.
-.--% | 09/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Carrie Cox
Empresas | Cargo | Inicio |
---|---|---|
TEXAS INSTRUMENTS INCORPORATED | Director/Board Member | 16/09/2004 |
ORGANON & CO. | Chairman | 02/06/2021 |
University of Pennsylvania Museum of Archaeology & Anthropolog | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Carrie Cox.
Empresas | Cargo | Fin |
---|---|---|
CARDINAL HEALTH, INC. | Director/Board Member | 15/11/2023 |
HUMACYTE, INC. | Chief Executive Officer | 01/06/2018 |
CANDEL THERAPEUTICS, INC. | Chairman | 15/07/2021 |
ELECTROCORE, INC. | Chairman | 31/03/2020 |
CELGENE | Director/Board Member | 01/11/2019 |
Formación de Carrie Cox.
Massachusetts College of Pharmacy & Health Science | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 6 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
TEXAS INSTRUMENTS INCORPORATED | Electronic Technology |
ELECTROCORE, INC. | Health Technology |
CANDEL THERAPEUTICS, INC. | Health Technology |
ORGANON & CO. | Health Technology |
HUMACYTE, INC. | Health Technology |
Empresas privadas | 12 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Pharmacia & Upjohn, Inc. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Prism Pharmaceuticals, Inc.
Prism Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prism Pharmaceuticals, Inc. manufactures cardiovascular injectables and pharmaceutical products. The firm engages in developing and commercializing branded cardiovascular injectable products which include NEXTERONE. The company was founded by Gilbert R. Gonzales and Cameron Durrant in 2003 and is headquartered in King of Prussia, PA. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Wyeth-Ayerst Research | |
University of Pennsylvania Museum of Archaeology & Anthropolog |
- Bolsa de valores
- Insiders
- Carrie Cox